Patient-specific risk factors include: Personal or family history of nephrolithiasis : Individuals with prior kidney stones have a recurrence rate of approximately 50% within 510 years, making this the strongest predictor of future stone formation
The exact dosage administered will vary from patient to patient and will be individually tailored to your needs after a thorough discussion of the results youre hoping to achieve
Recommended Adult Dose: Take one capsule daily with a meal or as recommended by your healthcare practitioner
Telemedicine consultations for convenient virtual visits
Abstract Pulmonary Hypertension (PH) is a life-threatening condition characterized by pulmonary vascular remodeling
Ipamorelin shows minimal effect No appetite stimulation: Unlike ghrelin itself, Ipamorelin does not significantly activate hunger pathways in published studies Published Research on Ipamorelin Study Model Key Finding Raun et al., 1998 (Eur J Endocrinol) Swine/Human Selective GH release without cortisol/prolactin elevation Johansen et al., 1999 Human (Phase I/II) Dose-response relationship with no significant adverse effects Bowers et al., 2004 Review Comparative analysis of GHRP selectivity profiles Head-to-Head Comparison Research Factor CJC-1295 Ipamorelin Receptor Target GHRH-R GHS-R1a (Ghrelin receptor) Signaling Pathway cAMP / PKA PLC / Calcium GH Release Pattern Amplifies natural pulsatile release Induces acute GH pulse Cortisol Impact Minimal Minimal Prolactin Impact Minimal Minimal Research Focus Sustained GH elevation models Selective/clean GH pulse models Typical Research Duration No DAC: 30min half-life / DAC: days ~2 hour half-life Why Researchers Study Them Together The combination of a GHRH analog (CJC-1295) with a GHRP (Ipamorelin) is well-documented in published literature
